This article is more than 5 years old. Information may no longer be current.
Allergan wins Botox trademark infringement suit
IRVINE, Calif. — Allergan was awarded a $1.5 million judgement against Mira Life Group, as a court in California ruled Mira Life “engaged in unfair competition and intentionally infringed the Botox trademark,” Allergan said in a press release.
The United States District Court in Santa Ana, Calif., ruled a cosmetic anti-wrinkle cream marketed by Mira Life as MiraBotex infringed upon Allergan’s Botox (botulinum toxin type A). The court also issued permanent injunctive relief preventing Mira Life from marketing any product with a name “confusingly similar” to Botox, Allergan said.
Allergan and Mira Life had initially reached a settlement requiring Mira Life to stop manufacturing packaging, labels or other materials promoting its MiraBotex name. When Mira Life continued to sell the product, Allergan filed suit, the company said.